BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 30

• Eurofarma Release: Brazilian Researchers Develop First Biosimilar In Latin America

  November 23, 2015

   · 

  4 min read
• BioForest

  BIO Statement On HHS Forum On Pharmaceutical Innovation, Access, Affordability And Better Health

  November 23, 2015

   · 

  1 min read
• Drug Development

  NovoCure Release: New Phase 3 Data Show Optune In Combination With Second Line Chemotherapy Is Superior To Second Line Chemotherapy Alone In Glioblastoma Patients At First Recurrence

  November 23, 2015

   · 

  5 min read
• Drug Development

  Exelixis Announces Presentation Of Positive Overall Survival Results For COTELLIC In Combination With Vemurafenib In Advanced BRAF V600 Mutation-Positive Melanoma At Society For Melanoma Research 2015 International Congress

  November 23, 2015

   · 

  14 min read
• Drug Development

  Tocagen Inc. Presents Interim Data From Studies Evaluating Toca 511 & Toca FC At The Annual Meeting Of The Society For Neuro-Oncology (SNO)

  November 23, 2015

   · 

  5 min read
• Genetown

  InspireMD Ltd. Announces Positive Twelve Month Follow-Up CARENET Trial Data At VEITH Symposium 2015

  November 23, 2015

   · 

  6 min read
• Business

  Kadmon Announces Agreement With Jinghua Pharmaceutical Co. To Discover, Develop And Commercialize Antibody Product Candidates In China

  November 23, 2015

   · 

  2 min read
• Business

  Boston Therapeutics Reports Third Quarter Results And Provides Corporate Update

  November 23, 2015

   · 

  12 min read
• Genetown

  Proteostasis Therapeutics, Inc. Demonstrates Therapeutic Potential Of A Proprietary Triple Combination Therapy For The Treatment Of Cystic Fibrosis That Restores Activity Of Mutant F508del CFTR Protein To 80% Of Normal

  November 23, 2015

   · 

  3 min read
• Drug Development

  WCCT Commits To Cardiovascular Research With AHA Certification At Phase 1 CPU

  November 23, 2015

   · 

  3 min read